Therefore, the improvement of adiponectin levels in women with obesity and/or gestational diabetes may serve as an effective intervention strategy in preventing the intrauterine transmission of obesity and metabolic disease [13]. This evidence concerns the gene ADIPOQ and gestational diabetes.